Progress in Treatment of Post Inflammatory Pulmonary Fibrosis Induced by SARS-CoV-2 Infection postprint

Abstract: Severe acute respiratory syndrome coronavirus 2（SARS-CoV-2）infection is a major public health emergency in the world in the past century，which poses a major threat to the global health system. After rehabilitation from SARS-CoV-2 infection，some patients may experience multiple respiratory symptoms for a long time，which is called the acute sequelae of SARS-CoV-2 infection. Post-COVID-19 pulmonary fibrosis（PCPF）as one of them，can affect the respiratory function and quality of life of patients to varying degrees. Regarding the treatment of PCPF is a hot topic in current research，and this article provides a review of treatment methods for PCPF，aiming to improve the prognosis of PCPF patients.